NKTR Drug delivery Company | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
NKTR Drug delivery Company

An SI Board Since September 2005

Posts	SubjectMarks	Bans	Symbol
507	31	0	NKTR

Emcee: david nordic	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
32	I will say though, that other catalysts give me comfort in the face of uncertain	tuck	-	2/16/2006
31	Interesting discussion of Exubera's prospects in the link below. There seem	tuck	-	2/16/2006
30	Nektar Announces That U.S. FDA Has Granted Orphan Drug Designation to the First	Rocky9	-	2/14/2006
29	Some color from NYT on the approval -- including the royalty rate of 15% of sale	tuck	-	1/28/2006
28	Nektar Therapeutics (NKTR - $ 20.62) 1-Overweight Lehman Brothers Jan 27, 200	Asymmetric	-	1/28/2006
27	Motley Fool Challenges Needle Novo Nordisk Friday January 27, 11:34 am ET By S	John McCarthy	-	1/27/2006
26	I hear the FDA decision is expected today. Here's an article that gives bri	tuck	-	1/27/2006
25	Has anyone ever seen such a fiasco caused by the (PFE) CEO when he went on CNBC	Arthur Radley	-	1/27/2006
24	Exubera approved for both types of diabetes in Europe: Message 22102460 Haven&	tuck	-	1/26/2006
23	"I continue to think that this could be one of the better biotechs for a lo	Rocky9	-	1/25/2006
22	I wrote Feb 17.50 calls a while ago, rolling up and out, so I think I am fairly	tuck	-	1/25/2006
21	Didn't like the way this one was trading...took all my money off the table y	Arthur Radley	-	1/25/2006
20	Right, I agree it's a bizarre position for said analyst to take, given what	tuck	-	1/19/2006
19	Tuck, I don't give any credence to what this analyst said or is accused of s	Arthur Radley	-	1/19/2006
18	A Deutsche analyst thinks FDA will approve the insulin but take a year to approv	tuck	-	1/19/2006
17	money.cnn.com	Arthur Radley	-	1/16/2006
16	News tonight...PFE buying Sanofi out for $1.3 billion dollars for full control o	Arthur Radley	-	1/12/2006
15	Cramer on NKTR ... Nektar Therapeutics (NKTR:Nasdaq - commentary - research - C	John McCarthy	-	1/9/2006
14	money.cnn.com Nice mention of Exubera..	Arthur Radley	-	1/9/2006
13	WIth all the upgrades & Bayer deal, NUVO seems no brainer. Not sure then wh	Raj Ramaswamy	-	1/6/2006
12	Appears that NKTR is finally picking up some steam as we approach European and F	Arthur Radley	-	1/6/2006
11	There appear to be some increased short term call activity for nktr this past fr	georgiabiotech	-	12/31/2005
10	Lot of activity today in the January 17.50 calls...and the bid is showing more i	Arthur Radley	-	12/22/2005
9	>>WASHINGTON (Dow Jones)--Nektar Therapeutics (NKTR) registered to sell $3	tuck	-	12/22/2005
8	Given that backdrop of slow, steady acceptance, I expect slow, steady share pric	david nordic	-	12/20/2005

Go to reply# or date (mm/dd/yy):